Use of adipose tissue-derived stromal stem cells in treating fistula

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11672831
APP PUB NO 20170189451A1
SERIAL NO

15464149

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are novel methods and composition utilizing adipose tissue-derived stromal stem cells for treating fistulae.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • TAKEDA PHARMACEUTICAL COMPANY LIMITED; UNIVERSIDAD AUTÓNOMA DE MADRID CIUDAD UNIVERSITARIA DE CANTOBLANCO CRTA.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fernández, Miguel María Gema Madrid, ES 8 28
García, Arranz Mariano Madrid, ES 7 28
García, Castro Rosa Ana Madrid, ES 7 28
García, Olmo Damián Madrid, ES 7 28
González, De La Peña Manuel Ángel Madrid, ES 5 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 13, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 13, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 13, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00